Cargando…
Cytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer
Co-delivery of microRNAs and chemotherapeutic drugs into tumor cells is an attractive strategy for synergetic breast cancer therapy due to their complementary mechanisms. In this work, a core-shell nanocarrier coated by cationic albumin was developed to simultaneously deliver miRNA-34a and docetaxel...
Autores principales: | Zhang, Li, Yang, Xin, Lv, Yaqi, Xin, Xiaofei, Qin, Chao, Han, Xiaopeng, Yang, Lei, He, Wei, Yin, Lifang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382875/ https://www.ncbi.nlm.nih.gov/pubmed/28383524 http://dx.doi.org/10.1038/srep46186 |
Ejemplares similares
-
Core-shell nanocarriers with high paclitaxel loading for passive and active targeting
por: Jin, Zhu, et al.
Publicado: (2016) -
Fluorophore Localization Determines the Results of Biodistribution of Core-Shell Nanocarriers
por: Hinz, Alicja, et al.
Publicado: (2022) -
Optimization of Synthesis Parameters for Mesoporous Shell Formation on Magnetic Nanocores and Their Application as Nanocarriers for Docetaxel Cancer Drug
por: El-Toni, Ahmed Mohamed, et al.
Publicado: (2013) -
Isolation of phosphooligosaccharide/phosphoinositol glycan from caveolae and cytosol of insulin-stimulated cells
Publicado: (1995) -
Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer
por: Wang, Qi, et al.
Publicado: (2017)